Task Description Request Please post to the 2017 Pharmacy Inspections and Related Records Web page
Record Date 03/23/2017
FEI Number 3013341563
Firm Name Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceutical
Record Type 483
State CA
Establishment Type Producer of Sterile Drug Products
Similar Posts
Laboratory Manual of Quality Policies (ISO 17025 Requirements)
Laboratory Manual of Quality Policies (ISO 17025 Requirements)Cosmetic Manufacturers Pty Ltd. – 719225 – 02/06/2026
CGMP/Finished Pharmaceuticals/AdulteratedEugia Pharma Specialities Limited – 2/6/2026
Eugia Pharma Specialities Limited – 2/6/2026. Country: India. Record Type: 483Innovative Science and Technology Approaches for New Drugs (ISTAND) Program
The Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program is designed to expand DDT types by encouraging development of DDTs that are out of scope for existing DDT qualification programs but may still be beneficial for drug development.FDA Rationale for Recognition Decision: Isavuconazonium sulfate
FDA Rationale for Recognition Decision: Isavuconazonium sulfateNational Drug Code Directory
National Drug Code Directory